Stieh, D. J., Tomaka, F., Comeaux, C. A., Nijs, S., Callewaert, K., Hendriks, J., … Schuitemaker, H. (2019). ASCENT: Phase 2a, randomized, double-blind, placebo controlled study evaluating safety and immunogenicity of two HIV-1 prophylactic vaccine regimens comprising Ad26. Mos4. HIV and either clade C gp140 or bivalent gp140. In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (Vol. 22, pp. 98–98). JOHN WILEY & SONS LTD.

Stieh, D. J., F. Tomaka, C. A. Comeaux, S. Nijs, K. Callewaert, J. Hendriks, Z. Euler, et al. “ASCENT: Phase 2a, randomized, double-blind, placebo controlled study evaluating safety and immunogenicity of two HIV-1 prophylactic vaccine regimens comprising Ad26. Mos4. HIV and either clade C gp140 or bivalent gp140.” In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 22:98–98. JOHN WILEY & SONS LTD, 2019.

Stieh DJ, Tomaka F, Comeaux CA, Nijs S, Callewaert K, Hendriks J, et al. ASCENT: Phase 2a, randomized, double-blind, placebo controlled study evaluating safety and immunogenicity of two HIV-1 prophylactic vaccine regimens comprising Ad26. Mos4. HIV and either clade C gp140 or bivalent gp140. In: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. JOHN WILEY & SONS LTD; 2019. p. 98–98.

Stieh, D. J., et al. “ASCENT: Phase 2a, randomized, double-blind, placebo controlled study evaluating safety and immunogenicity of two HIV-1 prophylactic vaccine regimens comprising Ad26. Mos4. HIV and either clade C gp140 or bivalent gp140.” JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, vol. 22, JOHN WILEY & SONS LTD, 2019, pp. 98–98.

Stieh DJ, Tomaka F, Comeaux CA, Nijs S, Callewaert K, Hendriks J, Euler Z, Tomaras GD, Alter G, Kublin J, Corey L, McElrath J, Swann E, Robb M, Michael N, Marovich M, Pau MG, Barouch DH, Schuitemaker H. ASCENT: Phase 2a, randomized, double-blind, placebo controlled study evaluating safety and immunogenicity of two HIV-1 prophylactic vaccine regimens comprising Ad26. Mos4. HIV and either clade C gp140 or bivalent gp140. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. JOHN WILEY & SONS LTD; 2019. p. 98–98.